The role of patient, tumour and system factors in socioeconomic inequalities in lung cancer treatment: Population-based study

British Journal of Cancer

Volumn 111, Issue 3, 2014, Pages 608-618

  Forrest, L F ^a,b   White, M ^a,b   Rubin, G ^a,c   Adams, J ^a,b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c DURHAM UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER STATISTICS; CANCER SURGERY; COHORT ANALYSIS; COMORBIDITY; FEMALE; FUNCTIONAL STATUS; HEALTH CARE DISPARITY; HISTOPATHOLOGY; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; POPULATION RESEARCH; PRIORITY JOURNAL; SOCIOECONOMICS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COMORBIDITY; ENGLAND; FEMALE; HEALTH SERVICES ACCESSIBILITY; HEALTHCARE DISPARITIES; HUMANS; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RISK FACTORS; SOCIOECONOMIC FACTORS;

EID: 84905229690     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.310     Document Type: Article

References (35)

1. Adams J, White M, Forman D (2004) Are there socioeconomic gradients in the quality of data held by UK cancer registries? J Epidemiol Community Health 58: 1052-1053.
2. Bennett V, Davies E, Jack R, Mak V, Moller H (2008) Histological subtype of lung cancer in relation to socio-economic deprivation in South East England. BMC Cancer 8(1): 139.
3. Berglund A, Lambe M, Lüchtenborg M, Linklater K, Peake MD, Holmberg L, Møller H (2012) Social differences in lung cancer management and survival in South East England: a cohort study. BMJ Open 2(3): e001048.
4. Charlson M, Pompei P, Ales K, MacKenzie C (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40: 373-383.
5. Coleman MP, Forman D, Bryant H, Butler J, Rachet B, Maringe C, Nur U, Tracey E, Coory M, Hatcher J, McGahan CE, Turner D, Marrett L, Gjerstorff ML, Johannesen TB, Adolfsson J, Lambe M, Lawrence G, Meechan D, Morris EJ, Middleton R, Steward J, Richards MA (2011) Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 377(9760): 127-138.
6. Dixon-Woods M, Cavers D, Agarwal S, Annandale E, Arthur A, Harvey J, Hsu R, Katbamna S, Olsen R, Smith L, Riley R, Sutton A (2006) Conducting a critical interpretive synthesis of the literature on access to healthcare by vulnerable groups. BMC Med Res Methodol 6(1): 35-47.
7. Forrest LF (2013) Why are socioeconomic inequalities in receipt of treatment found for lung cancer? Lung Cancer Manage 2(3): 177-180.
8. Forrest LF, Adams J, Wareham H, Rubin G, White M (2013a) Socioeconomic inequalities in lung cancer treatment: systematic review and meta-analysis. PLoS Med 10(2): e1001376.
9. Forrest LF, White M, Rubin G, Adams J (2013b) The effect of socioeconomic inequalities in receipt of, and time to, treatment on socioeconomic inequalities in lung cancer survival: an observational, data-linkage study. Lancet 382: S37.
10. Hirsch FR, Spreafico A, Novello S, Wood MD, Simms L, Papotti M (2008) The prognostic and predictive role of histology in advanced non-small cell lung cancer: a literature review. J Thorac Oncol 3(12): 1468-1481.
11. HM Government (2013) English Indices of Deprivation 2010.
12. Jack RH, Gulliford MC, Ferguson J, Møller H (2006) Explaining inequalities in access to treatment in lung cancer. J Eval Clin Pract 12(5): 573-582.
13. Louwman WJ, Aarts MJ, Houterman S, van Lenthe FJ, Coebergh JWW, Janssen-Heijnen MLG (2010) A 50% higher prevalence of life-shortening chronic conditions among cancer patients with low socioeconomic status. Br J Cancer 103(11): 1742-1748.
14. Lüchtenborg M, Jakobsen E, Krasnik M, Linklater KM, Mellemgaard A, Møller H (2012) The effect of comorbidity on stage-specific survival in resected non-small cell lung cancer patients. Eur J Cancer 48(18): 3386-3395.
15. Ludbrook JJS, Truong PT, MacNeil MV, Lesperance M, Webber A, Joe H, Martins H, Lim J (2003) Do age and comorbidity impact treatment allocation and outcomes in limited stage small-cell lung cancer? A community-based population analysis. Int J Radiat Oncol Biol Phys 55(5): 1321-1330.
16. Murdoch C, Wilkinson J, Unsworth L (2010) Lung resection rates across the North of England Cancer Network. Available at http://www.nepho.org.uk/ publications.php5?rid=823.
17. Murphy MM, Tseng JF, Shah SA (2010) Disparities in cancer care: an operative perspective. Surgery 147(5): 733-737.
18. NHS Information Centre (2012) National Lung Cancer Audit Report 2012. Leeds: NHS Information Centre for Health and Social Care. Available at www.hqip.org.uk/../Lung-Cancer-National-Audit-Report-pub-2012.pdf
19. NICE (2005) Clinical Guideline 24. Lung Cancer: the Diagnosis and Treatment of Lung Cancer. NICE: London.
20. Nutbeam D (2008) The evolving concept of health literacy. Soc Sci Med 67(12): 2072-2078.
21. NYCRIS (2012) Northern and Yorkshire Cancer Registry and Information Centre. Available at http://www.nycris.nhs.uk/about/. Accessed on 02 August 2013.
22. Parsons A, Daley A, Begh R, Aveyard P (2010) Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. Br Med J 340: b5569.
23. Protheroe J, Brooks H, Chew-Graham C, Gardner C, Rogers A (2013) Permission to participate? A qualitative study of participation in patients from differing socio-economic backgrounds. J Health Psychol 18(8): 1046-1055.
24. Rachet B, Ellis L, Maringe C, Chu T, Nur U, Quaresma M, Shah A, Walters S, Woods L, Forman D, Coleman MP (2010) Socioeconomic inequalities in cancer survival in England after the NHS cancer plan. Br J Cancer 103(4): 446-453.
25. Riaz SP, Linklater K, Horton M, Peake M, Moller H, Luchtenborg M (2010) Lung cancer data in the National Cancer Data Repository, Hospital Episode Statistics and National Lung Cancer Audit datasets. Available at www.ncin.org.uk/view?rid=1624.
26. Riaz SP, Lüchtenborg M, Coupland VH, Spicer J, Peake MD, Møller H (2012) Trends in incidence of small cell lung cancer and all lung cancer. Lung Cancer 75(3): 280-284.
27. Rich AL, Tata LJ, Free CM, Stanley RA, Peake MD, Baldwin DR, Hubbard RB (2011a) Inequalities in outcomes for non-small cell lung cancer: the influence of clinical characteristics and features of the local lung cancer service. Thorax 66(12): 1078-1084.
28. Rich AL, Tata LJ, Stanley RA, Free CM, Peake MD, Baldwin DR, Hubbard RB (2011b) Lung cancer in England: Information from the National Lung Cancer Audit (LUCADA). Lung Cancer 72(1): 16-22.
29. Sharpe KH, McMahon AD, McClements P, Watling C, Brewster DH, Conway DI (2012) Socioeconomic inequalities in incidence of lung and upper aero-digestive tract cancer by age, tumour subtype and sex: a population-based study in Scotland (2000-2007). Cancer Epidemiol 36(3): e164-e170.
30. Sobin LH, Wittekind CH (1997) TNM Classification of Malignant Tumors. 5th edn. John Wiley & Sons: New York, NY, USA.
31. Sorensen J, Klee M, Palshof T, Hansen H (1993) Performance status in cancer patients. An inter-observer variability study. Br J Cancer 67: 773-775.
32. Sterne JA, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, Wood AM, Carpenter JR (2009) Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. Br Med J 338: b2393.
33. White IR, Royston P, Wood AM (2011) Multiple imputation using chained equations: issues and guidance for practice. Stat Med 30(4): 377-399
34. WHO (World Health Organisation) (2000) International Classification of Diseases for Oncology (3rd (ICD-0-3)) (Accessed on 30 April 2014).
35. Woods LM, Rachet B, Coleman MP (2006) Origins of socio-economic inequalities in cancer survival: a review. Ann Oncol 17(1): 5-19.